News

Oncoinvent reports positive data from phase 1/2a trial of Radspherin in patients with colorectal peritoneal metastases: Oslo, Norway Thursday, June 19, 2025, 11:00 Hrs [IST] Oncoi ...
Bengaluru: What began as a celebration turned into tragedy — and for months, a slice of cake was wrongly blamed. A final investigation has now confirm.
ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...
Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO ...
Cleveland Clinic Abu Dhabi has achieved a significant medical milestone by performing the UAE’s first robotic cytoreductive ...
Results, presented simultaneously in oral presentation at ASCO 2025 and in peer-reviewed Gynecologic Oncology, suggest very meaningful survival effect of IMNN-001 in women HRP and HRD positive, ...
Stomach cancer is becoming more common in the United States: The American Cancer Society expects about 30,300 cases to be diagnosed in 2025, up from 26,800 last year. In many people, the disease can ...
These two catheters are connected via a programmable valve that allows excess CSF to drain from the ventricle into the peritoneal cavity. This new minimally invasive method does not require a ...
Peritoneal mesothelioma starts in the cells that make up the mesothelial lining of the abdominal cavity and typically spreads diffusely in the abdominal area. Diffuse spread means that the edges ...
Drug delivery systems can alter drug clearance from the peritoneal cavity and drug toxicity profiles. For example, IP injection of cisplatin-loaded polymeric microspheres (100–200 µm ...